Register now for our free workshop! Express your Tech: communicating your complex innovation
Thursday 5 October 2023 | 3:00pm to 6:30pm | St John’s Innovation Centre, Cowley Road, Cambridge, CB4 0WS
You’ve spent years on research and product development, and now it’s time to take your product or service to market. But how do you sum it up in a sentence that excites investors? How do you put yourself in your customer’s shoes and pinpoint how your offer solves their problems? How do you tailor your message for the different channels and platforms?
Innovate UK EDGE and Cambridge digital…
Artificial Intelligence (AI) is changing the future of all industries, but findings published today by intellectual property firm, Marks & Clerk, reveal the medical technology (medtech) sector is surging ahead. The number of AI-based patent applications filed by the sector has almost quadrupled since 2018 to 2771 medtech publications in 2022. But most strikingly, as a standalone sector, the year-on-year percentage growth in the number of AI applications filed repeatedly surpassed that of overall AI between 2014 and 2021.
Breaking the findings down by subsector, the report reveals the…
Alignment with U.S. FDA on design of Phase 2/3 registrational trial, to be initiated in 1Q 2024
Innovative study design allows for potential accelerated approval in untreated (first-line) and previously treated (second-line plus) metastatic bladder cancer
Conference call and webcast today at 8 a.m. ET
CAMBRIDGE, England & BOSTON--(BUSINESS WIRE)--Sep. 11, 2023-- Bicycle Therapeutics (Nasdaq: BCYC), a biotechnology company pioneering a new and differentiated class of therapeutics based on its proprietary bicyclic peptide (Bicycle®) technology, today…
Zurich, Switzerland and Cambridge, UK, September 2023 – Biotechgate, a leading global life sciences business development and licensing database and One Nucleus, a Cambridge, UK-based life sciences and healthcare membership organisation, are thrilled to announce a collaboration to boost life sciences connectivity and innovation. The purpose of this collaboration is to provide a reliable hub of information for professionals, organizations, and individuals across the industry by enhancing connections and promoting innovation.
A highlight of this partnership is the provision of a comprehensive…
Huge congratulations to Dr Sally Ann Forsyth OBE, CEO, Stevenage Bioscience Catalyst, who has been awarded an Honorary Doctorate from the University of Hertfordshire in recognition of her lifetime achievements in science, on Tuesday 5 September at the start of the University of Hertfordshire’s annual graduation ceremony taking place over two weeks at St Albans Cathedral.
Sally Ann said: “I feel very privileged to have been awarded an Honorary Doctorate in Science by the University of Hertfordshire. Life sciences has underpinned my whole career. I am immensely grateful to…
Strengthens supply chain for AqFresh™ air quality technology, as demand growsNew modular system designed for straight-forward integration into manufacturers’ existing plantsCements partnership between Aqdot and Menadiona
Cambridge, UK & Palafolls, Spain – Under a recently signed agreement, Aqdot, the specialist chemtech company, will install a modular manufacturing system at Menadiona’s Palafolls site. This will increase annual manufacturing capacity of AqFresh™ to 500 tonnes, in response to increasing demand for this versatile indoor air quality technology.
Menadiona will…
One Nucleus member, Appleyard Lees LLP, is a leading intellectual property firm supporting their clients to protect and monetise their IP, and manage post-grant challenges that could arise.
Recently, team members at Appleyard Lees shared some interesting insights into:
8 August - 'MADD GEAR takes on The Range at the UK IPO and wins' by Chris Hoole, Beverley Robinson and Lisa Thomson
31 August - 'Has the EPO abolished the 10-day rule?' By Kate Hickinson
6 September - 'When will European supplementary protection certificates (SPCs) have unitary effect?' By Kate Hickinson…
Partnership to provide customers with direct access to portfolio of highly characterized hepatic cells to recreate advanced Liver-on-a-Chip assays
Pre-validated cells alleviate the need for stringent in-house quality control testing to maximize assay success
Cambridge, UK, 06 September 2023: CN Bio, a leading Organ-on-a-Chip (OOC) company that designs and manufactures single-and multi-organ microphysiological systems (MPS), and LifeNet Health LifeSciences, “LifeNet Health”, a non-profit, global leader in all-human research solutions, today announced a strategic partnership to supply…
AMSBIO has supplied a custom monoclonal antibody (mAB) to researchers at the TU Dortmund** in Germany to unravel the role of EDI3 in breast cancer development, its regulation by HER2 signalling, and its potential as a therapeutic target.
Characterized by the overexpression of the Human Epidermal growth factor Receptor 2 (HER2) - HER2+ breast cancer is a highly aggressive disease subtype. While HER2-targeted treatments have improved patient outcomes for this form of cancer, acquired and inherent resistance to these treatment remains a challenge, prompting…
Did you know...
Ireland's life sciences sector exports more than 45 billion Euros annually and employs over 50,000 people?
All but one of the world's 25 largest biotech and pharma companies have a presence in Ireland?
Ireland is the world's third largest exporter of pharmaceuticals and has over 50 FDA approved pharma and biopharma plants?
What can Biocair and Aramex Ireland do to support you?
They have a fully integrated service managed by the Aramex network with Biocair's expertise.
Creation and assistance with shipment paperwork and labelling to ensure a swift and compliant…